Armata Pharmaceuticals, Inc.
ARMP
$5.41
-$0.41-7.05%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 74.14M | -115.35M | -124.30M | -26.68M | -16.30M |
| Total Depreciation and Amortization | 591.00K | 457.00K | 418.00K | 370.00K | 366.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -80.49M | 108.21M | 117.24M | 20.19M | 10.71M |
| Change in Net Operating Assets | -2.91M | 899.00K | -33.00K | 1.81M | -2.00M |
| Cash from Operations | -8.67M | -5.78M | -6.67M | -4.30M | -7.21M |
| Capital Expenditure | -17.00K | -63.00K | -52.00K | -242.00K | -149.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -17.00K | -63.00K | -52.00K | -242.00K | -149.00K |
| Total Debt Issued | 25.00M | -- | 0.00 | 15.00M | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.88M | 704.00K | 658.00K | -- | -- |
| Repurchase of Common Stock | 0.00 | -63.00K | 0.00 | -32.00K | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 27.88M | 641.00K | 658.00K | 14.97M | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 19.20M | -5.20M | -6.07M | 10.43M | -7.36M |